The clinical trials coordinated by MASC Trials are answering the many research questions emerging from the introduction of combined cancer treatment methods, such as our GoTHAM and CHARLI clinical trials.
Our clinical trials also explore how to improve diagnosis and how to prevent melanoma and skin cancer from reoccurring, such as our IMAGE trial and SiroSkin trials.
Surgical intervention – once the only option for melanoma and skin cancer patients – is now being refined through our world-wide MelMarT-II trial that will reduce the potential for disfigurement for patients and the burden on the healthcare system.
Our clinical trials are directly improving the lives of melanoma and skin cancer patients in Australia and around the world, while also reducing the burden on the healthcare system.